the-alfred hospital
Alfred Health researchers will play a major role in developing a global Fungal Pathogen Priority List (PPL) which will shed light on an often-overlooked group of infections.
A new device that targets hard-to-kill tumours is the focus of a research trial led by The Alfred's interventional radiology team.
Researchers at Melbourne Sexual Health Centre (MSHC) have been granted more than $1.25 million by the National Health and Medical Research Council (NHMRC) to develop new strategies for detecting and controlling syphilis.
A study conducted at The Alfred has proved what researchers had already predicted – that the neurological effects of COVID-19 could remain present months after the virus has been shed.
Researchers at The Alfred are hoping to break down the barriers people living with HIV encounter when it comes to undergoing solid organ transplantation.
This year, 22-year-old Demi Lawson has not only faced a global pandemic, but a diagnosis of brain cancer, an awake craniotomy (brain surgery) – and has been learning to live with the death of her younger brother.
One of Alfred Health’s leading physician-scientists has been recognised for his ground-breaking work in the area of infectious diseases.
Associate Professor Eric Chow from the Melbourne Sexual Health Centre and Monash University was recently awarded the 2020 Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.
The Alfred has banded together with a private IVF company to save a patient's chance of having children after he was diagnosed with testicular cancer.
Alfred Cancer Trials (ACT) has begun testing two new Phase 1 cancer drugs, treating the first patients in the world on these trials.